Core Insights - Aurora Cannabis Inc. is recognized as one of the 12 best marijuana stocks to buy according to analysts [1] - The company, in collaboration with Copeia, has launched an English-language version of the Physician Experience Platform (PEP), which includes over 130 anonymized case studies on medicinal cannabis treatments [1][2] - PEP aims to provide healthcare professionals with access to peer-reviewed clinical insights and is initially available in several countries including Canada, the UK, and Australia [1][2] Company Developments - The PEP platform builds on a successful German launch in 2024 and is secured by a DocCheck login for verified physicians [2] - Aurora Cannabis operates in the global medicinal and consumer cannabis markets under various brands such as MedReleaf, CanniMed, Drift, and San Rafael '71 [2] - The company intends to create an international medical cannabis case study database for physicians to upload cases in the future [2]

Core Insights - Cronos Group Inc. reported $33.5 million in net revenue for Q2 2025, marking a 21% increase year over year driven by strong cannabis flower sales in Israel and international markets, consolidation of Cronos GrowCo, and improved Canadian extract sales [1][3] - Gross profit rose from $8.2 million in Q2 2024 to $14.5 million, while adjusted EBITDA increased by $12.7 million to $1.7 million [1] - Despite revenue growth, Cronos reported a net loss of $38.5 million [1] Financial Performance - Net revenue for Q2 2025: $33.5 million, a 21% increase year over year [1] - Gross profit increased from $8.2 million to $14.5 million [1] - Adjusted EBITDA climbed to $1.7 million from the previous year's figure [1] - Net loss reported at $38.5 million [1] Market Position and Strategy - PEACE NATURALS® remains Israel's leading cannabis brand, contributing to record sales [3] - Planned growth in flower capacity and strong global momentum are expected to address supply limitations in Canada [3] - Flower sales generated approximately $2.2 million for Cronos GrowCo [3] - The company maintains a robust balance sheet with $834 million in cash and no debt, supporting international growth and brand innovation [3]

Industry Overview - The Canadian cannabis sector is crucial for investors looking to tap into the expanding U.S. marijuana market, which generated over $33 billion in sales in 2024 and is projected to exceed $50 billion by 2030 due to increasing state-level legalization and consumer demand [1][3] - Recent discussions around federal reform and rescheduling cannabis could benefit Canadian companies with U.S. partnerships or expansion plans, making them attractive to investors [1][3] Company Highlights - **Tilray Brands, Inc. (TLRY)**: - Operates in cultivation, processing, and distribution across Canada, Europe, and the U.S., focusing on hemp-derived beverages and wellness products, reaching about 1,000 retail stores [5][7] - Reported annual revenue of approximately $821 million with a gross profit of around $240 million, but net income remains negative with losses exceeding $2 billion [7] - **Canopy Growth Corporation (CGC)**: - One of the largest cannabis companies in Canada, with a strong presence in the U.S. through brands and subsidiaries rather than direct dispensary ownership [8][10] - Achieved year-over-year revenue growth of about 9%, but gross margin fell to 25% from 35% a year earlier, indicating financial strain [10] - **Village Farms International, Inc. (VFF)**: - Transitioned from agricultural production to cannabis, operating one of the largest cannabis greenhouse facilities in Canada with over 2.2 million square feet [12][14] - Reported annual revenue of about $336 million, a 17% increase from the previous year, but posted a net loss of approximately $36 million [14] Strategic Focus - Tilray is diversifying through beverages and wellness products, while Canopy is focusing on cost-cutting and U.S. brand partnerships [15] - Village Farms emphasizes efficiency and international expansion, positioning itself as one of the lowest-cost producers in Canada [14][15] Market Outlook - The Canadian cannabis sector faces challenges from oversupply and regulatory uncertainty, but leading companies are adapting their strategies to remain competitive [15][16] - September 2025 is seen as a critical period for the sector, with investors closely monitoring earnings, cost controls, and expansion efforts [16]

Company Overview - Vireo Growth Inc. has commenced the sale of adult-use cannabis at all eight Green Goods® dispensaries in Minnesota as of September 16, 2025 [1][2] - The company has been operating in Minnesota's medical cannabis market since 2014, serving tens of thousands of patients [2][4] - Vireo aims to expand access, improve product quality, and support the transition to a sustainable adult-use market in Minnesota [2][4] Market Impact - The launch of the adult-use cannabis market in Minnesota, with a population of 5.7 million, is expected to drive strong organic revenue growth for Vireo [1][2] - Vireo is one of the state's licensed adult-use cannabis cultivators and retailers, positioning itself to benefit from the new market dynamics [2][4] Product Offering - Green Goods® dispensaries offer a comprehensive range of medical and adult-use cannabis products, including flower, pre-rolls, edibles, and beverages [3][4] - The dispensaries are strategically located in key areas such as Minneapolis, Blaine, Bloomington, Burnsville, Duluth, Moorhead, Rochester, and Woodbury [3] Leadership Commentary - Amber Shimpa, President of Vireo, expressed pride in making products available to all Minnesotans while maintaining commitment to medical patients [3] - Alexandra Breant, Head of Market in Minnesota, highlighted the significance of this milestone in expanding access and building community [3]

Core Insights - Glow Lifetech Corp is expanding its MOD™ and .decimal™ brands into the Saskatchewan cannabis retail market, marking a significant step in its national growth strategy [1][2][3] Expansion Strategy - The expansion into Saskatchewan follows successful entries into Ontario and New Brunswick, with the company securing 10 product listings in Saskatchewan, which will create a new long-term revenue stream [2][4] - The company aims to leverage its success in Ontario to scale its operations nationally in a disciplined manner [2][3] Commercial Momentum - The Saskatchewan expansion is part of a broader strategy that includes deepening penetration in Ontario while entering new provinces [4][5] - Recent commercial progress indicates strong momentum, with MOD™ being established among Ontario's leading oil brands [4][5] Business Model and Innovation - Glow Lifetech's disciplined growth strategy combines expanded retail distribution, new provincial launches, and ongoing product innovation, reinforcing the fundamentals of the business [5] - The company's scalable model positions it for sustainable growth and long-term value creation [5]

WATCH: How Cheech & Chong Turned Their Legacy Into A $100 Million Cannabis Empire https://t.co/uS8VzUu0Wq https://t.co/QN6qtN7Ird ...

CHICAGO--(BUSINESS WIRE)--Cresco Labs Opens Sunnyside Proctorville, Strengthening Ohio Market Leadership. ...

Group 1 - Tilray Brands, Inc. is recognized as one of the 12 Best NASDAQ Penny Stocks to Buy According to Hedge Funds [1] - The partnership between Breckenridge Distillery and the Denver Broncos marks its fifth year, introducing a new lineup of limited-edition spirits [2][3] - The new collection includes unique products such as Broncos Honey Whiskey and Vodka Creamsicle Seltzer, celebrating Colorado and the Broncos' legacy [3][4] Group 2 - Jefferies analyst Kaumil Gajrawala raised the price target for Tilray Brands from $1.50 to $2, maintaining a Buy rating due to positive developments in cannabis regulation [5] - Tilray Brands operates in the lifestyle consumer products sector, focusing on medical cannabis through four segments: Beverage, Cannabis, Distribution, and Wellness [6]

Industry Overview - The U.S. administration is considering reclassifying marijuana from Schedule I to Schedule III under the Controlled Substances Act, which could significantly impact the marijuana industry by allowing businesses to access standard banking and reducing their effective tax rates [2] - Currently, marijuana's Schedule I classification limits business deductions under Section 280E of the federal tax code, which could change with reclassification, potentially increasing profitability and attracting institutional investors [2] Analyst Insights - TD Cowen analyst Jaret Seiberg suggests that former President Trump may revive efforts to move cannabis to Schedule III, allowing for government regulation [3] Best Marijuana Stocks - **Aurora Cannabis Inc. (NASDAQ: ACB)**: Analysts project an upside potential of 4.55%. The company launched the Physician Experience Platform (PEP) to provide healthcare professionals with access to clinical insights on medicinal cannabis treatments [8] - **Turning Point Brands, Inc. (NYSE: TPB)**: Analysts project an upside potential of 5.47%. The company launched Stoker's Fine Cut Wintergreen in a compact can, responding to consumer demand and enhancing its moist smokeless tobacco line [9][10] - **The Scotts Miracle-Gro Company (NYSE: SMG)**: Analysts project an upside potential of 12.90%. The company made significant strides in sustainability, including reducing water usage for greenhouse irrigation by over 50% and achieving 100% recyclable packaging for its products [11][12]

Core Viewpoint - Verano Holdings Corp. plans to redomicile from British Columbia, Canada, to Nevada, aiming to better align with its U.S. operations and streamline its organizational structure [1][2][3]. Group 1: Redomiciling Plan - The Board of Directors has approved a plan to seek shareholder approval for the redomiciling process [1][5]. - The move is expected to enhance shareholder value and create potential growth catalysts for the company [3]. - Upon completion, existing subordinate voting shares will be exchanged on a one-for-one basis for Nevada Common Stock [4]. Group 2: Business Operations - The redomiciling is not anticipated to materially impact Verano's existing manufacturing and retail operations across 13 U.S. states [3]. - The corporate headquarters will remain in Chicago, Illinois, ensuring continuity in operations [3]. Group 3: Shareholder Engagement - A preliminary proxy statement was filed to facilitate a special meeting for shareholders to consider the proposed plan [5]. - The Board retains the discretion to halt the arrangement even after receiving shareholder approval [5]. Group 4: Company Overview - Verano is a leading multi-state cannabis operator with a focus on providing high-quality cannabis products and a superior shopping experience [7]. - The company operates 15 production facilities with over 1.1 million square feet of cultivation capacity across 13 U.S. states [7].